Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: A randomized controlled trial

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Kløvstad, Hilde ^a   Natås, Olav ^b   Tverdal, Aage ^a   Aavitsland, Preben ^a,c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c Epidemi   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LYMECYCLINE;

ADULT; ARTICLE; CHLAMYDIASIS; COMPLICATION; CONTROLLED STUDY; DATA BASE; FEMALE; GENITAL TRACT INFECTION; HEALTH CARE SYSTEM; HOME SAMPLING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NORWAY; PATIENT CARE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLING; SCREENING; SYSTEMATIC SCREENING WITH INFORMATION; URINALYSIS;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; MALE; MASS SCREENING; NORWAY; QUESTIONNAIRES; REPRODUCTIVE TRACT INFECTIONS; RISK; SPECIMEN HANDLING; YOUNG ADULT;

EID: 84872547496     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-30     Document Type: Article

References (42)

1. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362-1366. 10.1056/NEJM199605233342103, 8614421.
2. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992, 19:185-192. 10.1097/00007435-199207000-00001, 1411832.
3. Buchan H, Vessey M, Goldacre M, Fairweather J. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol 1993, 100:558-562. 10.1111/j.1471-0528.1993.tb15308.x, 8334091.
4. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992, 19:61-77.
5. European Centre for Disease Prevention and Control Annual Epidemiological Report on Communicable Diseases in Europe 2010 2011, Stockholm: ECDC, European Centre for Disease Prevention and Control.
6. Norwegian Institute of Public Health Genitale klamydiainfeksjoner i Norge 2011 2012, Oslo, Norway: Norwegian Institute of Public Health, Norwegian Institute of Public Health.
7. Klovstad H, Aavitsland P. Chlamydia trachomatis infections in Norway, 1986 to 2006, surveillance data. Sex Transm Dis 2009, 36:17-21. 10.1097/OLQ.0b013e31818653b0, 18923334.
8. Screening for chlamydial infection U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007, 147:128-134. Screening for chlamydial infection.
9. CDC Grand Rounds Chlamydia Prevention: Challenges and Strategies for Reducing Disease Burden and Sequale. MMWR 2011, 60:370-373. CDC Grand Rounds.
10. Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol 2009, 38:435-448.
11. Aavitsland P, Lystad A. Indikasjoner for testing for seksuelt overførbare infeksjoner med Chlamydia trachomatis. Tidsskr Nor Laegeforen 1995, 115:3141-3144.
12. Cecil JA, Howell MR, Tawes JJ, Gaydos JC, McKee KT, Quinn TC, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis 2001, 184:1216-1219. 10.1086/323662, 11598849.
13. Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002, 51:1021-1031.
14. Low N. Screening programmes for chlamydial infection: when will we ever learn?. BMJ 2007, 334:725-728. 10.1136/bmj.39154.378079.BE, 1847869, 17413173.
15. Van Der PB, Ferrero DV, Buck-Barrington L, Hook E, Lenderman C, Quinn T, et al. Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol 2001, 39:1008-1016. 10.1128/JCM.39.3.1008-1016.2001, 87865, 11230419.
16. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol 2001, 39:1751-1756. 10.1128/JCM.39.5.1751-1756.2001, 88020, 11325985.
17. Angles M, Angles DM, Refseth UH, Espelund M, Moi H, Storvold G, Jeansson S. A new automated method for isolation of Chlamydia trachomatis from urine eliminates inhibition and increases robustness for NAAT systems. J Microbiol Methods 2007, 70:416-423. 10.1016/j.mimet.2007.05.017, 17610971.
18. Skatteetaten Generelt om folkeregistrering. 2008, http://www.skatteetaten.no, Skatteetaten.
19. Aavitsland P. Use of laboratory testing for genital chlamydial infection in Norway. Qual Health Care 1993, 2:91-5. 10.1136/qshc.2.2.91, 1055091, 10131639.
20. Aavitsland P, Schoyen R. Use and yield of microbiological diagnosis of sexually transmitted Chlamydia trachomatis infections in Vestfold 1984-93. Tidsskr Nor Laegeforen 1995, 115:3125-7.
21. Andersen B, Olesen F, Moller JK, Ostergaard L. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. J Infect Dis 2002, 185:252-8. 10.1086/338268, 11807700.
22. van Bergen J, Gotz H, Richardus JH, Hoebe C, Broer J, Coenen T. Prevalence of urogenital Chlamydia trachomatis infections in the Netherlands suggests selective screening approaches. Results from the PILOT CT Population Study. Drugs Today (Barc) 2006, 42(Suppl A):25-33.
23. van Bergen JE, Fennema JS, Van Den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, et al. Rationale, design, and results of the first screening round of a comprehensive, register-based. Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis 2010, 10:293.
24. Macleod J, Salisbury C, Low N, McCarthy A, Sterne JA, Holloway A, et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 2005, 330:940. 10.1136/bmj.38413.663137.8F, 556339, 15809231.
25. Scholes D, Heidrich FE, Yarbro P, Lindenbaum JE, Marrazzo JM. Population-Based Outreach for Chlamydia Screening in Men: Results from a Randomized Trial. Sex Transm Dis 2007, 34:837-839. 10.1097/OLQ.0b013e31805ba860, 17538514.
26. Gotz HM, van Bergen JE, Veldhuijzen IK, Hoebe CJ, Broer J, Coenen AJ, et al. Lessons learned from a population-based chlamydia screening pilot. Int J STD AIDS 2006, 17:826-30. 10.1258/095646206779307577, 17212860.
27. Lippman SA, Jones HE, Luppi CG, Pinho AA, Veras MA, van de Wijgert JH. Home-based self-sampling and self-testing for sexually transmitted infections: acceptable and feasible alternatives to provider-based screening in low-income women in Sao Paulo. Brazil. Sex Transm Dis 2007, 34:421-8.
28. European Centre for Disease Prevention and Control Review of chlamydia control activities in EU countries. Technical report. Project SCREen. European Centre for Disease Prevention and Control 2008, Stockholm: Sweden, European Centre for Disease Prevention and Control.
29. Bakken IJ, Nordbo SA, Skjeldestad FE. Chlamydia trachomatis testing patterns and prevalence of genital chlamydial infection among young men and women in central Norway 1990-2003: a population-based registry study. Sex Transm Dis 2006, 33:26-30. 10.1097/01.olq.0000187929.36118.d2, 16385219.
30. Graseck AS, Shih SL, Peipert JF. Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2011, 9:183-94. 10.1586/eri.10.164, 3097250, 21342066.
31. Novak DP, Karlsson RB. Simplifying chlamydia testing: an innovative Chlamydia trachomatis testing approach using the internet and a home sampling strategy: population based study. Sex Transm Infect 2006, 82:142-7. 10.1136/sti.2005.016832, 2564688, 16581742.
32. Bakken IJ, Skjeldestad FE, Nordbo SA. Testing pattern and prevalence of Chlamydia infections among men. Tidsskr Nor Laegeforen 2005, 125:1634-6.
33. Bakken IJ, Nordbo SA, Skjeldestad FE. Testing pattern and prevalence of Chlamydia infection among women]. Tidsskr Nor Laegeforen 2005, 125:1631-3.
34. Bakken IJ, Skjeldestad FE, Halvorsen TF, Thomassen T, Storvold G, Nordbo SA. Chlamydia trachomatis Among Young Norwegian Men: Sexual Behavior and Genitourinary Symptoms. Sex Transm Dis 2007, 34:245-249. 10.1097/01.olq.0000233737.48630.03, 16924179.
35. Scholes D, Grothaus L, McClure J, Reid R, Fishman P, Sisk C, et al. A randomized trial of strategies to increase chlamydia screening in young women. Prev Med 2006, 43:343-50. 10.1016/j.ypmed.2006.04.019, 16782182.
36. Shafer MA, Tebb KP, Pantell RH, Wibbelsman CJ, Neuhaus JM, Tipton AC, et al. Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls. JAMA 2002, 288:2846-52. 10.1001/jama.288.22.2846, 12472326.
37. Van Den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Gotz HM, Hoebe CJ, et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ 2012, 345:e4316. 10.1136/bmj.e4316, 3390168, 22767614.
38. Andersen B, Gundgaard J, Kretzschmar M, Olsen J, Welte R, Oster-Gaard L. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections. Sex Transm Dis 2006, 33:407-15. 10.1097/01.olq.0000200609.77577.3f, 16601656.
39. Schmid B, Over E, Van Den Broek I, Op de Coul E, van Bergen J, , et al. CSI Group Chlamydia screening implementation is not cost effective 2011, Quebec, Canada: Poster. ISSTDR Conference, CSI Group.
40. Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000, 31:951-7. 10.1086/318139, 11049776.
41. Andersen B, Van V,I, Sokolowski I, Moller JK, Ostergaard L, Olesen F. Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Sex Transm Infect 2011, 87:156-61. 10.1136/sti.2010.042192, 21097811.
42. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010, 340:c1642. 10.1136/bmj.c1642, 2851939, 20378636.